Suppr超能文献

接受根治性放疗与辅助放疗的宫颈癌患者放射性肠炎的发生率

Incidence of radiation enteritis in cervical cancer patients treated with definitive radiotherapy versus adjuvant radiotherapy.

作者信息

Wang Yinuo, Kong Weimin, Lv Nanan, Li Fengshuang, Chen Jiao, Jiao Simeng, Ding Ding, Zhao Hui, Song Dan

机构信息

Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China.

Department of Family Planning, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China.

出版信息

J Cancer Res Ther. 2018;14(Supplement):S120-S124. doi: 10.4103/0973-1482.163762.

Abstract

OBJECTIVE

The study aimed to evaluate the incidence of early and late radiation enteritis in cervical cancer patients receiving definitive or adjuvant radiotherapy (RT).

MATERIALS AND METHODS

Three hundred and twenty-four cervical cancer patients receiving definite or adjuvant RT in our hospital from January 2010 to December 2012 were divided into definitive (132 patients) or adjuvant RT (192 patients) and performed detailed analysis.

RESULTS

Early radiation enteritis was found in 54.3%, and late radiation enteritis was found in 17.9% of cervical patients. Early (P < 0.007) and late (P < 0.003) radiation enteritis appeared more frequently in patients treated with definitive RT than that with adjuvant RT. In the definitive RT group, incidence of both early and late radiation enteritis in the RT group was higher than in the radiochemotherapy (RCHT) group, and the difference was statistically significant (P < 0.004). Severe cases of late radiation enteritis (Grade 3 and 4) can be seen higher in the definitive radiation group (both the RT and RCHT group) than in the adjuvant radiation group, and the difference was statistically significant (P < 0.005).

CONCLUSION

The incidence of both early and late radiation enteritis in the definitive RT group is higher than in the adjuvant RT group. The occurrence of side effects was associated with the prolongation of total irradiation time due to necessary interruptions of RT. Methods to decrease the interruptions in the RT and the irradiated volume of the small bowel will further lessen enteric morbidity.

摘要

目的

本研究旨在评估接受根治性或辅助性放疗(RT)的宫颈癌患者早期和晚期放射性肠炎的发生率。

材料与方法

将2010年1月至2012年12月在我院接受根治性或辅助性RT的324例宫颈癌患者分为根治性放疗组(132例患者)和辅助性放疗组(192例患者),并进行详细分析。

结果

宫颈癌患者中,早期放射性肠炎的发生率为54.3%,晚期放射性肠炎的发生率为17.9%。接受根治性RT的患者早期(P < 0.007)和晚期(P < 0.003)放射性肠炎的发生率高于接受辅助性RT的患者。在根治性RT组中,RT组早期和晚期放射性肠炎的发生率均高于放化疗(RCHT)组,差异具有统计学意义(P < 0.004)。根治性放疗组(RT组和RCHT组)晚期放射性肠炎的严重病例(3级和4级)高于辅助性放疗组,差异具有统计学意义(P < 0.005)。

结论

根治性RT组早期和晚期放射性肠炎的发生率均高于辅助性RT组。副作用的发生与RT必要中断导致的总照射时间延长有关。减少RT中断和小肠照射体积的方法将进一步降低肠道发病率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验